Flumatinib mesylate
目录号: A13530
c-Abl/c-Kit/PDGRFβ 抑制剂
Flumatinib mesylate 可以在时间和剂量依赖的方式下降低 U266 细胞系中 C-MYC、HIF-1α 和 VEGF 的表达,因此 flumatinib mesylate 可能成为治疗多发性骨髓瘤(MM)的新药。
Discription | Flumatinib mesylate can reduce the expression of C-MYC, HIF-1 a and VEGF in U266 cell line in a time- and dose-dependent manners, so flumatinib mesylate may become a new drug for MM therapy. |
---|
目录号 | A13530 |
---|---|
分子式 | C30H33F3N8O4S |
分子量 | 658.69 |
CAS号 | 895519-91-2 |
SMILES | CC1=C(C=C(C=N1)NC(=O)C2=CC(=C(C=C2)CN3CCN(CC3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5.CS(=O)(=O)O |
储存条件 | Store lyophilized at -20ºC, keep desiccated. |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2